Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Chemoradiation With Weekly Oxaliplatin in High Risk Resected HNSCC
NCT00256308Phase 2Terminated
- Sponsor
- University of California, Irvine
- Start
- Feb 2005
- Primary completion
- May 2010
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in squamous cell carcinoma of the head and neck (HNSCC), sponsored by University of California, Irvine. Started Feb 2005; status: terminated.
02
Drugs
oxaliplatin
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00256308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00256308.